Drugs / Targeted CAR-T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07475182 | Dec 2025 → Dec 2027 expected | high grade malignant neoplasm | Hainan Cancer Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Targeted CAR-T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07475182 ↗ |
| Action | Deplete | “precisely and persistently killing cancer cells” NCT07475182 ↗ |
| Modality | Cell therapy | “Autologous T cells genetically modified to express chimeric antigen receptor (CAR)” NCT07475182 ↗ |